A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.

Abstract : Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization.
Document type :
Journal articles
Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-00683846
Contributor : Peter Sommer <>
Submitted on : Saturday, March 31, 2012 - 12:46:35 PM
Last modification on : Monday, October 8, 2018 - 5:44:04 PM

Identifiers

Collections

Citation

Junwon Kim, Taedong Ok, Changmin Park, Wonyoung So, Mina Jo, et al.. A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.. Bioorganic and Medicinal Chemistry Letters, Elsevier, 2012, 22 (7), pp.2522-6. ⟨10.1016/j.bmcl.2012.01.133⟩. ⟨pasteur-00683846⟩

Share

Metrics

Record views

120